 |
0 Diseases |  |
70 Trials |
|
70 Trials |  |
3689 News |  |
| «12...68697071727374757677787980» |
- | venlafaxine / Generic mfg., fluoxetine / Generic mfg.
New P4 trial: Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression (clinicaltrials.gov) - Apr 2, 2013
P4, N=200, Recruiting, Sponsor: Capital Medical University
- |||||| fluoxetine / Generic mfg.
Enrollment open: A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing (clinicaltrials.gov) - Mar 25, 2013
P3, N=522, Recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting
- |||||||||| fluoxetine / Generic mfg.
New P3 trial: A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing (clinicaltrials.gov) - Mar 7, 2013
P3, N=200, Active, not recruiting, Sponsor: Eli Lilly and Company
- |||||||||| fluoxetine / Generic mfg.
New P3 trial: A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing (clinicaltrials.gov) - Mar 7, 2013
P3, N=522, Recruiting, Sponsor: Eli Lilly and Company
- fluoxetine / Generic mfg.
New P1/2 trial: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Feb 27, 2013
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
- | New P4 trial: Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications (clinicaltrials.gov) - Feb 19, 2013
P4, N=500, Recruiting, Sponsor: Centre Hospitalier Universitaire Vaudois
- fluoxetine / Generic mfg.
Enrollment change: FDA BDD: Fluoxetine in Pediatric Body Dysmorphic Disorder (clinicaltrials.gov) - Feb 3, 2013
P4, N=17, Completed, Sponsor: Montefiore Medical Center
Not yet recruiting --> Recruiting N=37 --> 17
- fluoxetine / Generic mfg.
Biomarker, Trial completion: Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study) (clinicaltrials.gov) - Feb 3, 2013
P4, N=26, Completed, Sponsor: University of California, Los Angeles
N=37 --> 17 Recruiting --> Completed
- fluoxetine / Generic mfg.
Trial completion: FDA BDD: Fluoxetine in Pediatric Body Dysmorphic Disorder (clinicaltrials.gov) - Feb 3, 2013
P4, N=17, Completed, Sponsor: Montefiore Medical Center
Recruiting --> Completed Recruiting --> Completed
- ||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
Enrollment change: Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) (clinicaltrials.gov) - Jan 27, 2013
P3, N=3000, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting --> Completed N=1209 --> 3000
- Vyvanse (lisdexamfetamine) / Shionogi, Takeda
Enrollment open: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (clinicaltrials.gov) - Jan 25, 2013
P2, N=50, Recruiting, Sponsor: University of California, Los Angeles
N=1209 --> 3000 Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
Enrollment open: Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression (clinicaltrials.gov) - Jan 15, 2013
P=N/A, N=20, Recruiting, Sponsor: Lorie Ritschel, PhD
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | New P4 trial: AGTs-MDD: Algorithm Guided Treatment Strategies for Major Depressive Disorder (clinicaltrials.gov) - Jan 8, 2013
P4, N=1080, Recruiting, Sponsor: Shanghai Mental Health Center
- |||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
Trial completion: Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Dec 18, 2012
P2, N=1036, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- || fluoxetine / Generic mfg.
New P3 trial: FMRICH: Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage (clinicaltrials.gov) - Nov 27, 2012
P3, N=86, Recruiting, Sponsor: Universidad Autónoma de Aguascalientes
- |||||| olanzapine/fluoxetine / Generic mfg., fluoxetine / Generic mfg.
Enrollment open: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression (clinicaltrials.gov) - Nov 1, 2012
P3, N=229, Recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
Trial completion: Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy (clinicaltrials.gov) - Nov 1, 2012
P=N/A, N=60, Completed, Sponsor: University of California, Davis
Not yet recruiting --> Recruiting Recruiting --> Completed
- Vyvanse (lisdexamfetamine) / Shionogi, Takeda
New P2 trial: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (clinicaltrials.gov) - Oct 23, 2012
P2, N=50, Recruiting, Sponsor: University of California, Los Angeles
- fluoxetine / Generic mfg.
Trial completion, Adherence: Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy (clinicaltrials.gov) - Oct 15, 2012
P2, N=150, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Recruiting --> Completed
- | valsartan / Generic mfg., fluoxetine / Generic mfg.
New P4 trial: Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder (clinicaltrials.gov) - Oct 1, 2012
P4, N=200, Recruiting, Sponsor: National Cheng-Kung University Hospital
- ||| fluoxetine / Generic mfg.
Trial completion: A Study of LY110140 in Healthy Japanese Male Participants (clinicaltrials.gov) - Sep 27, 2012
P1, N=56, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| olanzapine/fluoxetine / Generic mfg., fluoxetine / Generic mfg.
New P3 trial: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression (clinicaltrials.gov) - Sep 17, 2012
P3, N=229, Recruiting, Sponsor: Eli Lilly and Company
- fluoxetine / Generic mfg.
Enrollment open: The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression (clinicaltrials.gov) - Sep 8, 2012
P2a, N=1, Recruiting, Sponsor: Taipei Medical University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
New P2a trial: The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression (clinicaltrials.gov) - Aug 21, 2012
P2a, N=1, Recruiting, Sponsor: Taipei Medical University Hospital
- fluoxetine / Generic mfg.
Enrollment change: Comparing Cognitive Behavioral Therapy, Antidepressant Medication, and Combined Treatment in Individuals With Hypochondriasis (clinicaltrials.gov) - Aug 13, 2012
P1/2, N=94, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting N=132 --> 94
- fluoxetine / Generic mfg.
Trial completion: Comparing Cognitive Behavioral Therapy, Antidepressant Medication, and Combined Treatment in Individuals With Hypochondriasis (clinicaltrials.gov) - Aug 13, 2012
P1/2, N=94, Completed, Sponsor: Brigham and Women's Hospital
N=132 --> 94 Active, not recruiting --> Completed
- fluoxetine / Generic mfg.
Enrollment open: HOMDEP-MENOP: Homeopathic Treatment for Depression in Peri- and Postmenopausal Women (clinicaltrials.gov) - Aug 12, 2012
P2, N=189, Recruiting, Sponsor: Hospital Juarez de Mexico
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- |||| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie
Trial completion: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder (clinicaltrials.gov) - Jul 24, 2012
P2, N=262, Completed, Sponsor: Forest Laboratories
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=100, Completed, Sponsor: Tirat Carmel Mental Health Center
Active, not recruiting --> Completed Recruiting --> Completed
- | fluoxetine / Generic mfg.
New P2 trial: HOMDEP-MENOP: Homeopathic Treatment for Depression in Peri- and Postmenopausal Women (clinicaltrials.gov) - Jul 5, 2012
P2, N=189, Recruiting, Sponsor: Hospital Juarez de Mexico
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial completion: Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning (clinicaltrials.gov) - Jun 26, 2012
P4, N=80, Completed, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
Enrollment closed: Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) (clinicaltrials.gov) - Jun 25, 2012
P3, N=3000, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- fluoxetine / Generic mfg.
Enrollment change: The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity (clinicaltrials.gov) - Jun 17, 2012
P=N/A, N=36, Completed, Sponsor: University of Washington
Not yet recruiting --> Active, not recruiting N=25 --> 36
- fluoxetine / Generic mfg.
Trial completion: The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity (clinicaltrials.gov) - Jun 17, 2012
P=N/A, N=36, Completed, Sponsor: University of Washington
N=25 --> 36 Recruiting --> Completed
- fluoxetine / Generic mfg.
Trial initiation date: A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture (clinicaltrials.gov) - Jun 5, 2012
P=N/A, N=82, Recruiting, Sponsor: The University of Hong Kong
Recruiting --> Completed Initiation date: Dec 2011 --> Jun 2012
- ||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
Enrollment change: Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder (clinicaltrials.gov) - May 14, 2012
P2, N=850, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Initiation date: Dec 2011 --> Jun 2012 N=635 --> 850
- ||| fluoxetine / Generic mfg.
New P1 trial: A Study of LY110140 in Healthy Japanese Male Participants (clinicaltrials.gov) - Mar 29, 2012
P1, N=56, Completed, Sponsor: Eli Lilly and Company
- | fluoxetine / Generic mfg.
Enrollment closed: Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms (clinicaltrials.gov) - Mar 26, 2012
P3, N=206, Active, not recruiting, Sponsor: Butler Hospital
N=635 --> 850 Recruiting --> Active, not recruiting
- | omeprazole / Generic mfg., fluoxetine / Generic mfg.
Trial completion: Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial (clinicaltrials.gov) - Mar 4, 2012
P2/3, N=144, Completed, Sponsor: Tehran University of Medical Sciences
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Trial completion: Treatment of Obsessive Compulsive Disorder in Children (clinicaltrials.gov) - Feb 20, 2012
P3, N=124, Completed, Sponsor: Duke University
Recruiting --> Completed Recruiting --> Completed
- fluoxetine / Generic mfg.
Trial completion: MSA-Fluox: Fluoxetine in Multiple System Atrophy Patients (clinicaltrials.gov) - Feb 19, 2012
P2, N=87, Completed, Sponsor: University Hospital, Toulouse
Recruiting --> Completed Recruiting --> Completed
- fluoxetine / Generic mfg.
Enrollment open: SMART: Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder. (clinicaltrials.gov) - Feb 7, 2012
P=N/A, N=240, Recruiting, Sponsor: Roseli Shavitt
Recruiting --> Completed Not yet recruiting --> Recruiting
- | fluoxetine / Generic mfg.
New P2 trial: Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression (clinicaltrials.gov) - Jan 11, 2012
P2, N=100, Recruiting, Sponsor: University of Michigan
- fluoxetine / Generic mfg.
Enrollment change: FAIR: Fluoxetine Essay in Children With Autism (clinicaltrials.gov) - Jan 8, 2012
P2, N=0, Withdrawn, Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting --> Recruiting N=30 --> 0
- || fluoxetine / Generic mfg.
New P3 trial: Fluoxetine or placebo for patients with a recent stroke (EUDRACT) - Jan 5, 2012
P3, N=3000, Ongoing, Sponsor: University of Edinburgh`NHS Lothian
- |||||| desvenlafaxine extended release / Generic mfg., fluoxetine / Generic mfg.
Enrollment open: A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD (clinicaltrials.gov) - Dec 12, 2011
P3, N=390, Recruiting, Sponsor: Pfizer
N=30 --> 0 Not yet recruiting --> Recruiting
- Clinical: Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder (clinicaltrials.gov) - Dec 3, 2011
P=N/A, N=90, Active, not recruiting, Sponsor: Korea University
- | New P4 trial, MRI: Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder (clinicaltrials.gov) - Oct 24, 2011
P4, N=80, Recruiting, Sponsor: Nanjing Medical University
- ||||||| duloxetine / Generic mfg.
Trial completion: A Study in the Treatment of Children and Adolescents With Major Depressive Disorder (clinicaltrials.gov) - Oct 13, 2011
P3, N=337, Completed, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
New P2 trial: Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Oct 4, 2011
P2, N=1036, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.